When pathological testing was in its infancy, the performance of the tests, which were usually fairly simple and limited in range, fell mainly into the domain of the junior doctor and the nursing staff. The procedures were often qualitative or only semiquantitative, requiring a minimum of apparatus, and could be carried out in the side-room of the ward, that is, relatively close to the patient. However, as scientific advances were made and applied to the study of disease, a wider range of tests was needed. Newer and better techniques were introduced to replace the old ones and to supplement them, and the side-room could no longer cope alone with the investigation of the patients on the ward. More specialised scientific knowledge and expertise began to develop within pathology departments, which gradually took over from the side-room as the main provider of pathology measurements, taking tests a little further away from the patient but still usually within the hospital.
Historical background
When pathological testing was in its infancy, the performance of the tests, which were usually fairly simple and limited in range, fell mainly into the domain of the junior doctor and the nursing staff. The procedures were often qualitative or only semiquantitative, requiring a minimum of apparatus, and could be carried out in the side-room of the ward, that is, relatively close to the patient. However, as scientific advances were made and applied to the study of disease, a wider range of tests was needed. Newer and better techniques were introduced to replace the old ones and to supplement them, and the side-room could no longer cope alone with the investigation of the patients on the ward. More specialised scientific knowledge and expertise began to develop within pathology departments, which gradually took over from the side-room as the main provider of pathology measurements, taking tests a little further away from the patient but still usually within the hospital.
The procedures employed in pathology laboratories were traditional manual techniques until the 1960s, when the first generation of automatic analysers was introduced. Since then the development of automatic instrumentation for pathology measurements has been rapid and continuous to the point where pathology laboratories have, with some justification, been likened to factories employing production-line techniques. The improvements in design of equipment have facilitated faster handling of samples but have inevitably been associated with increases in capital costs of equipment. This increased analytical capacity meant that one laboratory could process samples from other hospitals as well as its own, and economic considerations led to rationalization and centralisation of pathology services in most areas of the United Kingdom. These changes resulted in the closure of some smaller laboratories with concentration of *This essay was the winner in the 'under 35 section' of the 1979 Technicon Award.
Received for publication 15 January 1980 resources at the larger centres, a move that took pathology measurements yet another step away from many patients. It also introduced other problems, notably the organisation of transport facilities for samples and reports between hospitals and the district laboratory, which might be situated several miles from some of the beds it served.
The current situation is substantially the one just described, with pathology services relatively close to some patients, ie, those within the same hospital, and quite remote from others. An arrangement such as this is likely to offer a poorer service to the patients situated furthest from the laboratory unless a frequent and efficient transport system is in existence, and this can be a considerable financial burden, particularly if taxis are used to any significant extent for the transport of urgent specimens.
Another disadvantage of the large, centralised laboratory is that the service is likely to be dependent on a small number of large-capacity automatic analysers, and, if one of these breaks down, a large backlog of work builds up quite rapidly. There is therefore something to be said for having a more widely spread analytical capacity so that less reliance need be placed on any one instrument. A similar situation exists for the monitoring of patients on anticoagulant therapy. With the advent of rapid and simple enzyme-linked techniques for the assay of certain anticonvulsant drugs, this principle can now be applied to patients attending epileptic clinics, so that adjustments can be made to dosage on the spot, avoiding the effort and cost of informing patients by letter of any changes needed.
GENERAL WARDS
The scope for taking pathology measurements closer to the patient on the general hospital ward is still rather limited. It is common practice to perform a wide range of tests on almost every inpatient, and these tests are most economically done within the pathology department. However, it can be argued that many of these tests are unnecessary and that a more selective approach would be more sensible; but even then it is difficult to envisage routine pathology testing leaving the laboratory to be performed on the wards. There are systems under development, for example, the Kodak Ektachem system, that will enable analyses to be made without the use of wet chemical reagents and that should be suitable for performance by relatively unskilled staff. However, it requires a special spectrophotometer for quantitation, and the cost of materials per test result will probably be quite high.
CASUALTY DEPARTMENTS
It can be important in casualty departments to have ready access to certain pathological measurements. Some may be available at all times from the laboratory; others may not or may take time to organism, and it is this type of measurement that it would be desirable to have available within the casualty department. However, most procedures are too complicated to be performed under these conditions by untrained staff. Nevertheless, attempts have been made to introduce some analytical procedures; for example, a kit has been marketed for the measurement of paracetamol in blood, the intention being that this could be used at the bedside without the need for any other equipment. A blood alcohol estimation can also be helpful in the investigation of semiconscious and unconscious patients, and instruments are now available which can do this by breath analysis. This enables a rapid estimation to be carried out within the casualty department.
PATHOLOGY MEASUREMENTS BY PATIENTS
The ultimate in taking pathology measurements group.bmj.com on July 6, 2017 - Home monitoring by patients of blood glucose levels opens up a whole new aspect of the quality control of pathology tests. In most cases, the patients will have no analytical knowledge whatsoever, and the manufacturers of some of the systems provide no instructions for, or details of, quality control checks. Some of the instruments are precalibrated by the manufacturer, and there may be no means offered to the patient for checking this periodically. The situation should improve with further developments in this field but there is still likely to be considerable opportunity for error when analyses are being carried out by untrained amateurs.
ECONOMIC CONSIDERATIONS
The financial advantages that might accrue from resiting pathology testing closer to the patient stem partly from savings in salaries for laboratory staff, assuming that these are not replaced by other staff elsewhere. There would also be savings in capital costs of large-capacity automatic analysers although this would be offset by the costs of larger numbers of less expensive instruments to be sited nearer to the patients. A further saving would result from the elimination of sophisticated and expensive data processing systems that are currently in use in hospital laboratories for the handling of test information and reporting of results. Economies would also ensue from avoidance of expensive transport systems for samples and reports.
On the debit side, reagent costs would probably be higher because they would be used less economically and might often be in a specially prepared com drain. Improvements in electronic circuitry, together with a move to producing instruments specifically for a particular measurement, have resulted in direct-reading digital display models, which avoid the need for the operator to perform calculations. Indeed, in procedures where derived values are required, such as in blood gas analysis, there is now usually built into the instrument a calculator, which performs the appropriate computations.
The microprocessor revolution is already beginning to affect pathology laboratories in that some new instruments are being marketed with microprocessor control. This should make it even easier for a relatively unskilled operator to handle sophisticated pieces of equipment.
Step-by-step instructions can be given to the operator, and, if these are not followed correctly, error messages can be delivered. In conjunction with the largely automatic preprogrammed operation that is possible with microprocessor-controlled units, this should be very effective in eliminating operator error and should contribute to the quality of the results. Other 
Summary and conclusions
Continuing improvements in analytical systems are making pathology testing simpler to perform, and modern methods of investigation and treatment tend to require greater support in the form of information from pathology tests. These trends together have encouraged a move towards taking pathology testing closer to the patient. This should enable a quicker service to be given, but it is, of course, directly opposed to the moves towards centralisation which took place a few years ago and represents a return towards the side-room approach to pathology testing. An increased speed of service has obvious implications in terms of patient care, especially for those acutely ill and requiring constant supervision. However, apart from these superficial advantages, the way is far from clear for a wholesale shift of resources to this type of approach. It is necessary to consider the financial obligations of setting up a system for pathology testing and the number of patients who will benefit from it. It is difficult to generalise on this because both capital and running costs must be borne in mind, and the latter can be high for some systems. The saving in laboratory and transport costs must also be taken into account.
A cause for concern with some of the systems is that they depend on reagent materials produced by one manufacturer, making them rigid and possibly expensive. It also means that the choice of method will be made by the manufacturer without reference to the user. Another cause for concern is quality control, which may deteriorate if testing is to be dissipated throughout the hospital.
It is clear that only certain units in a hospital could justify having their own pathology tests available and even then only for certain parameters. This means that the laboratory would probably still have to provide a service for other units, so that duplication of facilities would occur.
In conclusion, the trend towards pathology testing closer to the patient should be viewed with cautious optimism. Each situation should be treated with individual attention. The advantages and disadvantages should be carefully weighed before a decision is taken regarding whether it is better for the laboratory to provide the necessary service or to site the testing elsewhere. The areas that look most attractive for the latter are close monitoring of acutely ill patients, those undergoing detailed investigation over a period of time, some outpatient clinics, casualty departments, and, in certain cases, patients at home.
